Morgan Stanley Allarity Therapeutics, Inc. Transaction History

Morgan Stanley

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$0.22 - $31640.0 $6,283 - $904 Million	28,562 Added 18915.23%	28,713 $8,000
Q3 2022 Nov 14, 2022	BUY	$1.04 - $34160.0 $3 - $102,480	3 Added 2.03%	151 $0
Q2 2022 Oct 27, 2022	SELL	$1.11 - $2.99 $35,258 - $94,974	-31,764 Reduced 99.54%	148 $0
Q2 2022 Aug 15, 2022	SELL	$1.11 - $2.99 $35,258 - $94,974	-31,764 Reduced 99.54%	148 $0
Q1 2022 Oct 27, 2022	BUY	$1.93 - $10.75 $61,304 - $341,463	31,764 Added 21462.16%	31,912 $65,000
Q1 2022 May 13, 2022	BUY	$1.93 - $10.75 $61,590 - $343,054	31,912 New	31,912 $65,000

Ticker ALLR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 10,260,200
Market Cap $35M
Description
Allarity Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in developing oncology therapeutics using drug-specific companion diagnostics generated by its drug response predictor technology. Its drug candidates include Stenoparib, a poly-ADP-ribose polymerase inhibitor that is in Phase 2 clinical trials for ovarian cancer; D...

Get notified when there are updates to the investment portfolio of Morgan Stanley, based on Form 13F filings with the SEC.

Stay updated on Morgan Stanley with notifications on news.